Brandywine Oak Private Wealth LLC Sells 808 Shares of CVS Health Co. (NYSE:CVS)

Brandywine Oak Private Wealth LLC cut its holdings in CVS Health Co. (NYSE:CVS) by 12.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,654 shares of the pharmacy operator’s stock after selling 808 shares during the period. Brandywine Oak Private Wealth LLC’s holdings in CVS Health were worth $446,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of CVS. Atticus Wealth Management LLC boosted its holdings in CVS Health by 149.0% in the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 219 shares during the period. Cornerstone Planning Group LLC boosted its holdings in CVS Health by 111.5% in the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 243 shares during the period. ZRC Wealth Management LLC boosted its holdings in CVS Health by 400.0% in the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after purchasing an additional 400 shares during the period. Coston McIsaac & Partners boosted its holdings in CVS Health by 42.6% in the 4th quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator’s stock valued at $42,000 after purchasing an additional 161 shares during the period. Finally, Tennessee Valley Asset Management Partners bought a new stake in shares of CVS Health during the 4th quarter worth $50,000. 80.66% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on CVS. Barclays began coverage on shares of CVS Health in a report on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price objective for the company. Cantor Fitzgerald downgraded shares of CVS Health from an “overweight” rating to a “neutral” rating and dropped their price objective for the stock from $87.00 to $58.00 in a report on Wednesday. Mizuho decreased their target price on shares of CVS Health from $86.00 to $72.00 and set a “buy” rating on the stock in a research report on Thursday. Royal Bank of Canada decreased their price objective on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a research report on Thursday, February 8th. Finally, Leerink Partnrs reaffirmed an “outperform” rating on shares of CVS Health in a research note on Monday, February 26th. Seven investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and an average price target of $83.50.

Insider Transactions at CVS Health

In other news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at approximately $3,059,916.75. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.24% of the company’s stock.

CVS Health Stock Performance

Shares of NYSE:CVS opened at $56.32 on Thursday. CVS Health Co. has a 52 week low of $54.00 and a 52 week high of $83.25. The stock has a market capitalization of $70.99 billion, a P/E ratio of 8.72, a PEG ratio of 0.90 and a beta of 0.56. The firm has a fifty day simple moving average of $73.63 and a two-hundred day simple moving average of $73.50. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping analysts’ consensus estimates of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The business had revenue of $93.81 billion during the quarter, compared to analysts’ expectations of $90.58 billion. During the same period last year, the company posted $1.99 EPS. The business’s revenue was up 11.9% on a year-over-year basis. On average, analysts expect that CVS Health Co. will post 8.31 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.72%. The ex-dividend date of this dividend was Friday, April 19th. CVS Health’s payout ratio is currently 41.18%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.